NCT03395886View on ClinicalTrials.gov

Remifentanil Versus Dexmedetomidine for Post-Cardiac Surgery Patients With Noninvasive Ventilation Intolerance

CompletedOBSERVATIONAL
Enrollment

90

Participants

Timeline

Start Date

January 1, 2018

Primary Completion Date

March 31, 2019

Study Completion Date

March 31, 2019

Conditions
Cardiac Surgery
Interventions
DRUG

Remifentanil

The noninvasive ventilation intolerated patients was sedated by remifentanil.

DRUG

Dexmedetomidine

The noninvasive ventilation intolerated patients was sedated by dexmeditomidine.

Trial Locations (1)

200030

Zhongshan hospital, Fudan university, Shanghai

All Listed Sponsors
lead

Shanghai Zhongshan Hospital

OTHER

NCT03395886 - Remifentanil Versus Dexmedetomidine for Post-Cardiac Surgery Patients With Noninvasive Ventilation Intolerance | Biotech Hunter | Biotech Hunter